Innovent Biologics Inc. held its annual general meeting on June 25, 2025. During the meeting, a proposal to extend the general mandate granted to the Directors to issue shares by adding the total number of shares to be bought back was approved. Additionally, the grant of 2,754,000 restricted shares to Dr. De-Chao Michael Yu was also approved.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Innovent Biologics Inc. published the original content used to generate this news brief on June 25, 2025, and is solely responsible for the information contained therein.